CORD-19:c654596857bce9cdd64ffc51842048643107348c / 161921-162229 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1359","span":{"begin":0,"end":308},"obj":"Sentence"},{"id":"T12358","span":{"begin":0,"end":308},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The bactericidal activity against Streptococcus pneumoniae of XRP2868, a new oral streptogramin composed of two semi-synthetic synergistic components in a 30/70 (w/w) association (RPR202868, pristinamycin I derivative and RPR132552, pristinamycin II derivative), was assessed in lungs of mice with pneumonia."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T106","span":{"begin":0,"end":308},"obj":"Sentence"}],"text":"The bactericidal activity against Streptococcus pneumoniae of XRP2868, a new oral streptogramin composed of two semi-synthetic synergistic components in a 30/70 (w/w) association (RPR202868, pristinamycin I derivative and RPR132552, pristinamycin II derivative), was assessed in lungs of mice with pneumonia."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T224","span":{"begin":48,"end":58},"obj":"Phenotype"},{"id":"T225","span":{"begin":298,"end":307},"obj":"Phenotype"}],"attributes":[{"id":"A224","pred":"hp_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A225","pred":"hp_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"The bactericidal activity against Streptococcus pneumoniae of XRP2868, a new oral streptogramin composed of two semi-synthetic synergistic components in a 30/70 (w/w) association (RPR202868, pristinamycin I derivative and RPR132552, pristinamycin II derivative), was assessed in lungs of mice with pneumonia."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T687","span":{"begin":34,"end":58},"obj":"Disease"},{"id":"T688","span":{"begin":298,"end":307},"obj":"Disease"},{"id":"T637","span":{"begin":34,"end":58},"obj":"Disease"},{"id":"T638","span":{"begin":298,"end":307},"obj":"Disease"}],"attributes":[{"id":"A687","pred":"mondo_id","subj":"T687","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A688","pred":"mondo_id","subj":"T688","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A62750","pred":"mondo_id","subj":"T637","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A83312","pred":"mondo_id","subj":"T638","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"The bactericidal activity against Streptococcus pneumoniae of XRP2868, a new oral streptogramin composed of two semi-synthetic synergistic components in a 30/70 (w/w) association (RPR202868, pristinamycin I derivative and RPR132552, pristinamycin II derivative), was assessed in lungs of mice with pneumonia."}